Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP348047.RAi3qj2AHkLNGAV4gBz1F-WHt6ooTr5KMjcyO1x72RY_g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP348047.RAi3qj2AHkLNGAV4gBz1F-WHt6ooTr5KMjcyO1x72RY_g130_assertion type Assertion NP348047.RAi3qj2AHkLNGAV4gBz1F-WHt6ooTr5KMjcyO1x72RY_g130_head.
- NP348047.RAi3qj2AHkLNGAV4gBz1F-WHt6ooTr5KMjcyO1x72RY_g130_assertion description "[APC/MCC, RAS, DCC, p53 mutations and/or allelic losses, hyperexpression of c-MYC and RB genes), as well as other genomic alterations, appear at characteristic stages of tumor development and are observed in most neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP348047.RAi3qj2AHkLNGAV4gBz1F-WHt6ooTr5KMjcyO1x72RY_g130_provenance.
- NP348047.RAi3qj2AHkLNGAV4gBz1F-WHt6ooTr5KMjcyO1x72RY_g130_assertion evidence source_evidence_literature NP348047.RAi3qj2AHkLNGAV4gBz1F-WHt6ooTr5KMjcyO1x72RY_g130_provenance.
- NP348047.RAi3qj2AHkLNGAV4gBz1F-WHt6ooTr5KMjcyO1x72RY_g130_assertion SIO_000772 16471312 NP348047.RAi3qj2AHkLNGAV4gBz1F-WHt6ooTr5KMjcyO1x72RY_g130_provenance.
- NP348047.RAi3qj2AHkLNGAV4gBz1F-WHt6ooTr5KMjcyO1x72RY_g130_assertion wasDerivedFrom befree-20150227 NP348047.RAi3qj2AHkLNGAV4gBz1F-WHt6ooTr5KMjcyO1x72RY_g130_provenance.
- NP348047.RAi3qj2AHkLNGAV4gBz1F-WHt6ooTr5KMjcyO1x72RY_g130_assertion wasGeneratedBy ECO_0000203 NP348047.RAi3qj2AHkLNGAV4gBz1F-WHt6ooTr5KMjcyO1x72RY_g130_provenance.